PNMA2
Paraneoplastic antigen Ma2
Also known as: MA2, PNMA2_HUMAN, RGAG2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UL42
- Gene
- PNMA2
- Ensembl
- ENSG00000240694
- Chromosome
- 8
- Canonical length
- 364 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be involved in positive regulation of apoptotic process. Predicted to be located in nucleolus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q9UL42|PNMA2
1 MALALLEDWC RIMSVDEQKS LMVTGIPADF EEAEIQEVLQ ETLKSLGRYR LLGKIFRKQE
61 NANAVLLELL EDTDVSAIPS EVQGKGGVWK VIFKTPNQDT EFLERLNLFL EKEGQTVSGM
121 FRALGQEGVS PATVPCISPE LLAHLLGQAM AHAPQPLLPM RYRKLRVFSG SAVPAPEEES
181 FEVWLEQATE IVKEWPVTEA EKKRWLAESL RGPALDLMHI VQADNPSISV EECLEAFKQV
241 FGSLESRRTA QVRYLKTYQE EGEKVSAYVL RLETLLRRAV EKRAIPRRIA DQVRLEQVMA
301 GATLNQMLWC RLRELKDQGP PPSFLELMKV IREEEEEEAS FENESIEEPE ERDGYGRWNH
361 EGDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNMA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 114 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 114 nTPM
- hypothalamus: 97 nTPM
- basal ganglia: 83 nTPM
- amygdala: 64 nTPM
- hippocampal formation: 56 nTPM
- midbrain: 36 nTPM
Single-cell type
- other brain neurons: 130 nCPM
- brain inhibitory neurons: 116 nCPM
- brain excitatory neurons: 68 nCPM
- pancreatic islet cells: 59 nCPM
- ependymal cells: 53 nCPM
- corticotrophs: 49 nCPM
Immune cell
- basophil: 0.7 nTPM
- naive B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- hypothalamus: 251 nTPM
- cerebral cortex: 214 nTPM
- basal ganglia: 176 nTPM
- hippocampal formation: 125 nTPM
- pons: 124 nTPM
- thalamus: 124 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PNMA2.
Disease | AutoantibodyPubMed
Conditions in which antibodies against PNMA2 are reported. Each links to that disease's full target list.
- Encephalitis 15
- Limbic Encephalitis 15
- Paraneoplastic Syndromes, Nervous System 13
- Lung Neoplasms 7
- Autoimmune Diseases of the Nervous System 6
- Hashimoto Disease 5
- Adenocarcinoma 3
- Brain Diseases 3
Showing 8 of 11 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for PNMA2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
55 publications
- Clinical analysis of anti-Ma2-associated encephalitis.
2004 · Brain · RCR 13.7 · 510 citations - Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
2008 · J Neurol Neurosurg Psychiatry · RCR 4.1 · 142 citations - Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.
2001 · Ann Neurol · RCR 3.7 · 152 citations - Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (I): Antibodies to Intracellular Antigens.
2025 · Neurol Neuroimmunol Neuroinflamm · RCR 3.1 · 8 citations - Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies.
2022 · Cancer Immunol Immunother · RCR 2.7 · 36 citations
Show 20 more of 55 total
- Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.
2018 · Neurologia (Engl Ed) · RCR 2.4 · 55 citations - Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.
2004 · Neurology · RCR 2.3 · 83 citations - Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis.
2007 · Neurology · RCR 2.3 · 75 citations - Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
2019 · J Neurol · RCR 2 · 36 citations - Paraneoplastic neurological syndromes: diagnosis and treatment.
2007 · Curr Opin Neurol · RCR 2 · 64 citations - Severe dysautonomia as a main feature of anti-GAD encephalitis: Report of a paediatric case and literature review.
2018 · Eur J Paediatr Neurol · RCR 1.9 · 31 citations - Narcolepsy, REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma.
2011 · Arch Neurol · RCR 1.8 · 53 citations - Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies.
2023 · Epilepsia · RCR 1.6 · 11 citations - Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.
2018 · J Med Case Rep · RCR 1.5 · 39 citations - Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.
2010 · PLoS One · RCR 1.4 · 51 citations - Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody.
2001 · J Neurol Neurosurg Psychiatry · RCR 1.4 · 49 citations - Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
2011 · Horm Metab Res · RCR 1.2 · 36 citations - Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes.
2007 · Mov Disord · RCR 1 · 33 citations - Treatment of paraneoplastic neurologic disorders.
2010 · Curr Treat Options Neurol · RCR 1 · 31 citations - Autoimmune sleep disorders.
2016 · Handb Clin Neurol · RCR 0.8 · 19 citations - Autoimmune encephalitis associated with Ma2 antibodies and immune checkpoint inhibitor therapy.
2020 · Pract Neurol · RCR 0.8 · 17 citations - Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer.
2000 · J Neurol Neurosurg Psychiatry · RCR 0.8 · 28 citations - Panhypopituitarism as the first sign of paraneoplastic limbic encephalitis in a patient with cured testicular cancer: a case report.
2022 · J Med Case Rep · RCR 0.5 · 4 citations - Upbeat nystagmus in anti-Ma2 encephalitis.
2014 · Pract Neurol · RCR 0.4 · 9 citations - Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report.
2020 · BMC Neurol · RCR 0.4 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PNMA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNMA2 as an antibody target. Whether an autoantibody or antibody against PNMA2 could matter depends on whether native PNMA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNMA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PNMA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...